Understanding the trade-offs of various software selection project approaches

Depending on my client’s priorities and appetite as it relates to timeline, budget and risk in the selection process, I recommend one of the following five approaches to software selection for the most important business applications (e.g., ERP, claims platform, loan origination): Standard software selection (10 to 12 weeks) – The most comprehensive and recommended option, with the longest...

Read More

They say variety is the spice of life – but does the same hold true for Big Data?

Last week Chicago was one of 29 host cities around the world for Big Data Week, a week-long series of workshops on big data and analytics.  I had the privilege of giving a ten minute “rapid-fire” talk about big data in banking and also attended a number of other workshops.  It was a fun, thought-provoking week full of interesting case studies and great networking between government...

Read More

Co-sourcing: What is it? Is it real? Is it worth doing?

George S Day wrote a Harvard Business Review article about measuring risk of innovation called “Is it real? Can we win? Is it worth doing?” It’s a great article about how companies can measure risk before moving into a new product or venture. I think this type of activity applies really well to most technology projects, including co-sourcing.…

Read More

Improving Technology Transfer through Collaboration – How Life Science and Pharma Organizations Can Manage Content While Minimizing Risk

If you read our recent post on “A Shifting Pharmaceutical Industry”, you know that the emerging ‘niche buster’ model is pushing organizations to become more flexible, nimble and collaborative as the breadth of their product portfolios increases. Despite the changes and challenges, organizations need to intelligently approach how they manage content and minimize the risks of tech transfer.…

Read More

A Shifting Pharmaceutical Industry

How is the Pharmaceutical Industry Shifting?  There’s no doubt that the declining number of blockbuster drugs on the market has caused a dramatic change in how pharmaceutical companies operate.  As the industry begins to realize that a blockbuster-driven  strategy is not in and of itself sufficient to drive growth, drug companies are starting to move away from the one size fits...

Read More

A Message from Dean Fischer, CEO

To our clients and friends,  It’s hard to believe another year is already coming to a close. This was a particularly noteworthy year for West Monroe Partners, as we celebrated our tenth anniversary. But as much as I enjoy reflecting on what has happened, doing so almost always draws me toward thinking about the futureand not just the future of our business, but what we can and should...

Read More

Enabling “Light Touch” Quality Management

Pharmaceutical companies are headed in a new direction in the non-blockbuster era. As a result, pharma leaders are in a unique position. This New World has resulted in widely dispersed and disparate operations.  Successful leaders will be those who harness the diversity and complexity, versus those who fight to centralize and control and would benefit from a light touch...

Read More

SharePoint 2013 Functional Preview

“The New SharePoint,” SharePoint 2013, promises to raise your expectations as a collaborative workplace tool. The WMP Enterprise Content Management Team will create weekly blog installments profiling the latest end user tools making SharePoint 2013 the best SharePoint experience to date!  Over the next quarter you’ll read about SharePoint 2013 and the...

Read More
Phone: 312-602-4000
Email: marketing@westmonroepartners.com
222 W. Adams
Chicago, IL 60606
Show Buttons
Share On Facebook
Share On Twitter
Share on LinkedIn
Hide Buttons